Litchman Manuel MD 4
4 · MUSTANG BIO, INC. · Filed Apr 3, 2023
Insider Transaction Report
Form 4
Litchman Manuel MD
DirectorPresident, CEO and Interim CFO
Transactions
- Award
COMMON STOCK, PAR VALUE $0.0001
2022-06-21+61,000→ 1,093,987 total - Purchase
COMMON STOCK, PAR VALUE $0.0001
2022-09-13$0.52/sh+5,000$2,582→ 1,098,987 total - Purchase
COMMON STOCK, PAR VALUE $0.0001
2022-03-18$0.74/sh+5,000$3,695→ 1,032,987 total
Footnotes (3)
- [F1]Shares acquired as purchases made under the Issuer's Employee Stock Purchase Plan ("ESPP") during the ESPP offering period.
- [F2]Includes restricted share units, which vest over various time periods.
- [F3]Represents an award of 61,000 restricted stock units that will vest in four annual installments after the grant date, vesting in full on April 24, 2026.